SEC Info - Ra Capital Management, L.P., et al. - ‘SC 13G’ on 12/17/20 re: Viridian Therapeutics, Inc./DE

SEC Info℠

Home

Help

Please Sign In

Ra Capital Management, L.P., et al. – ‘SC 13G’ on 12/17/20 re: Viridian Therapeutics, Inc./DE – ‘EX-1’

On: Thursday, 12/17/20, at 4:40pm ET · Accession #: 1104659-20-136895 · File #: 5-88625

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/17/20  Ra Capital Management, L.P.       SC 13G                 2:85K  Miragen Therapeutics, Inc.        Toppan Merrill/FA
          Peter Kolchinsky
          Ra Capital Healthcare Fund, L.P.
          Rajeev Shah

Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Sch. 13G — WA’68
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Acquisition of Beneficial Ownership    HTML     38K 
                by a "Passive" Investor                                          
 2: EX-1        Underwriting Agreement or Conflict Minerals Report  HTML      8K

‘EX-1’ — Underwriting Agreement or Conflict Minerals Report

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EXHIBIT 1

AGREEMENT

This Joint Filing Agreement, dated as of December 17, 2020, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”).

Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G and/or 13D with respect to Common Stock, par value $0.01 per share of Miragen Therapeutics, Inc. beneficially owned by them from time to time.

Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Filers hereby agree to file a single statement on Schedule 13G and/or 13D (and any amendments thereto) on behalf of each of such parties, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.

This Joint Filing Agreement may be terminated by any of the Filers upon one week’s prior written notice or such lesser period of notice as the Filers may mutually agree.

Executed and delivered as of the date first above written.

RA CAPITAL MANAGEMENT, L.P.

By:	/s/ *Peter Kolchinsky*
	Name:	Peter Kolchinsky
	Title:	Authorized Signatory

PETER KOLCHINSKY

/s/ Peter Kolchinsky

RAJEEV SHAH

/s/ Rajeev Shah

RA CAPITAL HEALTHCARE FUND, L.P.

By:	RA Capital Healthcare GP, LLC

By:	/s/ *Peter Kolchinsky*
	Name:	Peter Kolchinsky
	Title:	Manager

Dates Referenced Herein and Documents Incorporated by Reference

This ‘SC 13G’ Filing	Date	Other Filings

Filed on:	12/17/20	3, 8-K
		List all Filings

↑Top

Filing Submission 0001104659-20-136895 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)